Form 4: Rapid Micro Biosystems Director, Kirk Malloy, Receives Stock Options and Restricted Stock Units

Director Kirk Malloy of Rapid Micro Biosystems, Inc. received stock options and restricted stock units on May 23, 2024.

Summary

• On May 23, 2024, Kirk Malloy, a director at Rapid Micro Biosystems, Inc. (RPID), was granted 14,300 shares of Class A Common Stock as restricted stock units (RSUs).
• These RSUs will vest on the earlier of the first anniversary of the grant date or the day before the next annual meeting, contingent upon continuous service.
• Malloy also received options to purchase 28,650 shares of Class A Common Stock at an exercise price of $0.82.
• These options will vest and become exercisable on the earlier of the first anniversary of the grant date or the day before the next annual meeting, contingent upon continuous service, and will expire on May 22, 2034.
• Following these transactions, Malloy directly owns 14,300 shares of Class A Common Stock and options for 28,650 shares.

Sentiment

Score: 7

Explanation: The sentiment is neutral to slightly positive. The granting of stock options and RSUs is a standard practice and suggests confidence in the company's future performance. However, it's not a major event that would drastically alter investor sentiment.

Positives

• The grant of RSUs and stock options to a director aligns their interests with those of the shareholders.
• The vesting conditions tied to continuous service incentivize the director to remain with the company.

Industry Context

Stock grants and options are common forms of executive compensation in the biotechnology industry, aligning management's interests with shareholder value creation. These grants are designed to attract, retain, and incentivize key personnel.

Comparison to Industry Standards

• Stock option grants are a standard component of compensation packages for directors in publicly traded companies, particularly in growth-oriented sectors like biotechnology.
• Companies such as Illumina, Inc. and Thermo Fisher Scientific also utilize stock options and restricted stock units to incentivize their executives and directors.
• The vesting schedules, typically tied to continued service, are also in line with industry norms.

Stakeholder Impact

• Shareholders may view the stock options and RSUs positively as they align the director's interests with the company's long-term success.
• Employees may see this as a positive sign of the company's commitment to its leadership.

Key Dates